Artificial Heart

  • The first test

    The first test
    Dr. Kolff and Dr. Tetsuzo Akutsu test an artificial heart on a dog and it survives approximitaly 90 minutes http://www.syncardia.com/resources/artificial-heart-timeline.html
  • The first human trial

    The first human trial
    Ventriloquist Paul Winchell was granted the first artificial heart
    http://www.syncardia.com/resources/artificial-heart-timeline.html
  • Division of Artificial Organs

    Division of Artificial Organs
    Dr.Kloff starts his own artificial organs places at the University of Utah and continue his work on the artificial heart http://www.syncardia.com/resources/artificial-heart-timeline.html
  • Artificial Heart second test

    Artificial Heart second test
    Dr. Christiaan Barnard preforms the first heart transplant in Cape town South Africa, the paitent lives 18 days
    http://www.syncardia.com/resources/artificial-heart-timeline.html
  • Dr.Kloff steps down

    He steps down as CEO of Kloff Medical and is later renamed Symbion
  • The FDA closes Symbion

    The FDA closes Symbion due to violations of the FDA guidelines and regulations
  • A new initation

    UMC initiates a new FDA IDE clinical study of the Total Artificial Heart.
  • The CardioWest Artificial Heart

    The pivotal clinical study of the CardioWest temporary Total Artificial Heart is completed.
  • Excor portable power

    The Heart and Diabetes Center NRW in Bad Oeynhausen, Germany, pioneers the clinical study of the Excor portable driver for powering the Total Artificial Heart. The portable driver enables stable European patients to be discharged from the hospital while they wait for a matching donor heart for transplant.
  • FDA approves new studies

    March: FDA approves Investigational Study for new, smaller SynCardia Total Artificial Heart - The 50cc heart is the smaller version of the 70cc SynCardia Heart, which is FDA, Health Canada and CE mark approved. It is designed for implantation in most women, smaller men and many adolescents with end-stage biventricular heart failure.